Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery

Karolinska University Hospital600 enrolled

Overview

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Study Type

OBSERVATIONAL

Enrollment

600

Conditions

Minimally Invasive Cardiac Surgery

Interventions

Percutaneous vascular closureDEVICE

Percutaneous arteriotomy closed using a plug-based arteriotomy closure device

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device. Exclusion Criteria: * None.

Locations (1)

Karolinska University Hospital

Stockholm, Sweden

RECRUITING

Outcomes

Primary Outcomes

Any vascular groin-related complication

Time frame: During the first 8 weeks after surgery

Central Contacts

Magnus Dalén

CONTACT

+46 (0) 8 123 700 00 magnus.dalen@karolinska.se

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.